methaniazide has been researched along with Lung Diseases, Interstitial in 1 studies
methaniazide: RN given refers to parent cpd
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsushima, H | 1 |
| Sugita, Y | 1 |
| Yanagisawa, T | 1 |
| Ubukata, M | 1 |
| Kurosawa, T | 1 |
| Yoshida, F | 1 |
| Kanazawa, M | 1 |
1 other study available for methaniazide and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[A case of isoniazid sodium methanesulfonate induced interstitial pneumonia].
Topics: Aged; Antitubercular Agents; Humans; Isoniazid; Lung Diseases, Interstitial; Male; Tuberculosis, Pul | 2003 |